Literature DB >> 21497368

D2-40 immunoreactivity in penile squamous cell carcinoma: a marker of aggressiveness.

Daniele Minardi1, Gianluca d'Anzeo, Guendalina Lucarini, Alessandra Filosa, Antonio Zizzi, Oriana Simonetti, Massimo Polito, Anna Maria Offidani, Roberto Di Primio, Rodolfo Montironi, Giovanni Muzzonigro.   

Abstract

D2-40 immunohistochemical expression was investigated in tissue specimens from 39 patients with squamous cell carcinoma of the penis who underwent partial or total penectomy between 1987 and 2008. Patient age, tumor size, and grade; D2-40-positive lymphatic vessel density in intratumoral, peritumoral, and normal tissue; cell positivity for D2-40 in intratumoral and normal tissue; and D2-40 staining intensity and distribution were analyzed and correlated with disease-specific survival. Analysis of D2-40-positive lymphatics disclosed that mean lymphatic vessel density was greater in peritumoral tissue than in intratumoral and normal tissue and lower in patients with lymph node metastasis than in those without lymph node metastasis. The receiver operating characteristic curve showed that an intratumoral lymphatic vessel density greater than 2.0 had 83.3% sensitivity and 78% specificity in predicting lymph node metastasis. Analysis of cell immunoreactivity showed cytoplasmic D2-40 positivity in intratumoral and normal tissue in 89.7% and 65.5% of patients, respectively. A strong correlation emerged between grade of cell differentiation and D2-40 immunoreactivity in intratumoral tissue; in particular, 88.9% of tumors with weak podoplanin expression were G1, whereas strong cellular immunoreactivity was detected in 83.3% of G3 patients (P = .003; χ(2) test). A significant correlation was also noted between pattern of reactivity and tumor grade because the basal layer was positive in patients with undifferentiated tumors (100% of G3) and in 72.2% of G1 tumors (P = .021; χ(2) test). D2-40 seems to be a useful marker for the development of node metastasis in squamous cell carcinoma of the penis, although validation in larger series is required to confirm its predictive value.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21497368     DOI: 10.1016/j.humpath.2010.12.020

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  5 in total

1.  Prognostic value of CD44 expression in penile squamous cell carcinoma: a pilot study.

Authors:  Daniele Minardi; Guendalina Lucarini; Alessandra Filosa; Antonio Zizzi; Oriana Simonetti; Anna Maria Offidani; Gianluca d'Anzeo; Roberto Di Primio; Rodolfo Montironi; Giovanni Muzzonigro
Journal:  Cell Oncol (Dordr)       Date:  2012-09-13       Impact factor: 6.730

2.  Tumor-to-tumor metastasis from lung cancer: a clinicopathological postmortem study.

Authors:  Susumu Matsukuma; Takako Kono; Hiroaki Takeo; Yusuke Hamakawa; Kimiya Sato
Journal:  Virchows Arch       Date:  2013-08-03       Impact factor: 4.064

3.  Co-expression of podoplanin and fibroblast growth factor 1 predicts poor prognosis in patients with lung squamous cell carcinoma.

Authors:  Juan Li; Han Chen; Xiaoqing Li; Linlin Wang; Aiqin Gao; Pei Zhang; Wenli Lin; Wei Gao; Dong Yang; Xiaosun Guo; Jie Liu; Qi Dang; Yuping Sun
Journal:  Mol Med Rep       Date:  2017-06-21       Impact factor: 2.952

4.  Association of high PDPN expression with pulmonary metastasis of osteosarcoma and patient prognosis.

Authors:  Xincheng Wang; Wei Li; Jiaqi Bi; Jia Wang; Linying Ni; Qingtao Shi; Qinggang Meng
Journal:  Oncol Lett       Date:  2019-11-05       Impact factor: 2.967

5.  Clinicopathology significance of podoplanin immunoreactivity in esophageal squamous cell carcinoma.

Authors:  Wei Ma; Kai Wang; Shaoqi Yang; Jianbo Wang; Bingxu Tan; Bing Bai; Nana Wang; Yibin Jia; Ming Jia; Yufeng Cheng
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.